JPH06505975A - 環状リガンド - Google Patents
環状リガンドInfo
- Publication number
- JPH06505975A JPH06505975A JP4506056A JP50605692A JPH06505975A JP H06505975 A JPH06505975 A JP H06505975A JP 4506056 A JP4506056 A JP 4506056A JP 50605692 A JP50605692 A JP 50605692A JP H06505975 A JPH06505975 A JP H06505975A
- Authority
- JP
- Japan
- Prior art keywords
- ligand
- tables
- formulas
- ligand according
- chemical formulas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D341/00—Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6578—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and sulfur atoms with or without oxygen atoms, as ring hetero atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB9105898.2 | 1991-03-20 | ||
| GB919105898A GB9105898D0 (en) | 1991-03-20 | 1991-03-20 | Compounds useful as intermediates for binding ions to substrates |
| GB9125882.2 | 1991-12-05 | ||
| GB919125882A GB9125882D0 (en) | 1991-12-05 | 1991-12-05 | Cyclic ligands |
| PCT/GB1992/000492 WO1992016520A1 (en) | 1991-03-20 | 1992-03-19 | Macrocyclic thioether ligands and their use as intermediates for binding ions to substrates |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH06505975A true JPH06505975A (ja) | 1994-07-07 |
Family
ID=26298609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4506056A Pending JPH06505975A (ja) | 1991-03-20 | 1992-03-19 | 環状リガンド |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0576492A1 (de) |
| JP (1) | JPH06505975A (de) |
| CA (1) | CA2105872A1 (de) |
| GB (1) | GB2253850B (de) |
| WO (1) | WO1992016520A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5879657A (en) * | 1993-03-30 | 1999-03-09 | The Dupont Merck Pharmaceutical Company | Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| EP1015428B1 (de) * | 1997-09-18 | 2003-05-02 | Pierce Chemical Company | Sulfo-n-hydroxysuccinimide und verfahren zur ihren herstellung |
| US5892057A (en) | 1997-09-18 | 1999-04-06 | Pierce Chemical Company | Preparation of sulfo-N-hydroxysuccinimide salts |
| US20210228748A1 (en) * | 2017-02-08 | 2021-07-29 | Helmholtz-Zentrum Dresden - Rossendorf E.V. | In vivo stable hg-197(m) compounds, method for the production thereof and use thereof in nuclear medical diagnostics and endoradionuclide therapy (theranostics) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4782013A (en) * | 1987-07-23 | 1988-11-01 | Eastman Kodak Company | Photographic element containing a macrocyclic ether compound |
-
1992
- 1992-03-19 JP JP4506056A patent/JPH06505975A/ja active Pending
- 1992-03-19 EP EP19920906587 patent/EP0576492A1/de not_active Withdrawn
- 1992-03-19 GB GB9205992A patent/GB2253850B/en not_active Expired - Fee Related
- 1992-03-19 CA CA 2105872 patent/CA2105872A1/en not_active Abandoned
- 1992-03-19 WO PCT/GB1992/000492 patent/WO1992016520A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| GB2253850B (en) | 1994-11-09 |
| CA2105872A1 (en) | 1992-09-21 |
| EP0576492A1 (de) | 1994-01-05 |
| WO1992016520A1 (en) | 1992-10-01 |
| GB2253850A (en) | 1992-09-23 |
| GB9205992D0 (en) | 1992-04-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5183653A (en) | Boronic acid adducts of metal dioxime complexes useful in labelling proteins and other amine-containing compounds | |
| US5350837A (en) | Complexes with 99m Tc suitable for radiolabelling monoclonal antibodies or other macro molecules | |
| US4732974A (en) | Metal ion labeling of carrier molecules | |
| DE69126124T2 (de) | Polymere träger zur freisetzung kovalent gebundener wirkstoffe | |
| DE3650172T2 (de) | Diphosphonatderivierte Makromoleküle. | |
| US5601800A (en) | New multifunctional ligands for potential use in the design therapeutic or diagnostic radiopharmaceutical imaging agents | |
| JPH03504976A (ja) | 骨造影及び骨癌療法のための接合体 | |
| JP3097755B2 (ja) | 遷移金属の窒化物錯体の製造方法 | |
| US5219555A (en) | Method for labeling proteins with technetium or rhenium | |
| US5196515A (en) | Thiolactone bifunctional chelating agents for diagnostic and therapeutic products | |
| HUT73665A (en) | Bifunctional-chelating agents braked with calcogene atoms, pharmaceutical compositions containing them , and use of these compositions in radio- diagnosis and radiotherapy | |
| JPH06505975A (ja) | 環状リガンド | |
| Najafi et al. | Synthesis and preliminary evaluation of a new chelate N2S4 for use in labeling proteins with metallic radionuclides | |
| Gniazdowska et al. | Synthesis, radiochemistry and stability of the conjugates of technetium-99m complexes with Substance P | |
| Xu et al. | Synthesis and evaluation of hydroxamamide-based tetradentate ligands as a new class of thiol-free chelating molecules for 99mTc radiopharmaceuticals | |
| Papadopoulos et al. | Synthesis and characterization of five-coordinate rhenium (V) and technetium (V) mixed ligand bifunctional complexes carrying the SNS/S or the SNN/S donor atom set. Crystal structure of ReO {[(C2H5) 2NCH2CH2N (CH2CH2S) 2](p-H2N–PhS)} and ReO {[(CH2) 4NCH2CH2NCH2CH2S](p-H2N–PhS)} | |
| JP2020504103A (ja) | テクネチウム系化合物により高感受性及び感熱性の標的指向性生体分子を標識化する方法 | |
| McPherson et al. | Radiolabeling of proteins with radioisotopes of copper using p‐carboxyalkylphenylglyoxal bis‐(4N‐methylthiosemicarbazone)(TSC) bifunctional chelates | |
| Babich et al. | 6-Mercaptomethylpyridine-3-carboxylic acid (MEMNIC): a new reagent for peptide labeling with Tc-99m | |
| US6143275A (en) | Type S3 N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use | |
| US20100324319A1 (en) | Tame based chelators and uses thereof | |
| Leenhardt et al. | TrisOxine abiotic siderophores for technetium complexation: radiolabeling and biodistribution studies | |
| Boll et al. | Vallabhajosula S, Babich JW. Nucl Med Biol. 2017; 55: 38-46. | |
| Selivanova | Technetium-99M Complexes with 2-pyrollylthiones: A New Class of Radiopharmaceuticals for Medical Imaging | |
| GB2214507A (en) | 2,3-dithiosuccinic acid derivative and their use |